Nitric oxide in postmenopausal women taking three different HRT regimens

Maturitas

Volumn 50, Issue 1, 2005, Pages 52-57

  Kesim, M D ^a   Aydin, Y ^a   Erdemir, M ^a   Atis, A ^a,b  

^a SISLI ETFAL TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b Post Code: 81080   (Turkey)

Author keywords

Estrogen; Medroxyprogesterone acetate; Nitric oxide; Postmenopause; Tibolone

Indexed keywords

CONJUGATED ESTROGEN; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; ESTROGEN; GESTAGEN; NITRIC OXIDE; PLACEBO; TIBOLONE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HORMONE SUBSTITUTION; HUMAN; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, CUTANEOUS; CONTRACEPTIVE AGENTS, FEMALE; ESTROGEN RECEPTOR MODULATORS; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; ESTROGENS, CONJUGATED (USP); FEMALE; HUMANS; MEDROXYPROGESTERONE 17-ACETATE; MIDDLE AGED; NITRIC OXIDE; NORPREGNENES; POSTMENOPAUSE; PROSPECTIVE STUDIES;

EID: 10044268565     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2004.04.002     Document Type: Article

References (27)

1. Henderson, BE, Paganini-Hill, Aross, RK. Estrogen replacement therapy and protection from acute myocardial infarction. Am. J. Obstet. Gynecol. 1988;159:312-17.
2. Kuhn F.E., Rackley C.E. Coronary artery disease in women. Risk factors, evaluation, treatment and prevention. Arch. Intern. Med. 153:1993;2626-2636
3. Darkow D.J., Lu L., White R.E. Estrogen relaxation of coronary artery smooth muscle is mediated by nitric oxide and cGMP. Am. J. Physiol. 272:1997;2765-2773
4. Lang U., Baker R.S., Clark K.E. Estrogen-induced increases in coronary blood flow are antagonised by inhibitors of nitric oxide synthesis. Eur. J. Obstet. Gynecol. Reprod. Biol. 74:1997;229-235
5. Clark K.E., baker R.S., Lang U. Premarin induced increases in coronary and uterine blood flow. Am. J. Obstet. Gynecol. 182:2000;17-22
6. Manson J.E., Hsia J., Johonson K.C., et al. Estrogen plus progestin and the risk of coronary heart disease. N. Eng. J. Med. 349(6):2003;519-521
7. Grady D., Herrington D., Bittener V., et al. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/Progestin Replacement Study follow-up(HERSII). J. Am. Med. Assoc. 288(1):2002;49-57
8. Zoma W., Baker R.S., Lang U., Clark K.E. Hemodynamic response to tibolone in reproductive and non-reproductive tissues in the sheep. Am. J. Obstet. Gynecol. 184:2001;544-551
9. Van de Vies J. Pharmacological studies with (7 alpha,17 alpha)-17-hydroxy-7-methyl-19-norpregn-5810)-en-20-yn-3-one. Maturitas 1987;(Suppl 1):15-24.
10. Zanberg P., Peters J.L., Demacker P.N., Smit M.J., de Reeder E.G., Meuleman D.G. Tibolone prevents atherosclerotic lesion formation in cholesterol-fed overectomised rabbits. Arterioscler. Thromb. Vasc. Biol. 12:1998;1844-1854
11. Farish E., Barnes J.F., Rolton H.A., Spowart K., Fletcher C.D., Hart D.M. Effects of tibolone on lipoprotein(a) and HDL subfractions. Maturitas. 20:1994;215-219
12. Roselli M., Imthurn B., Keller P.J., Dubey R.K. Circulating nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17β-estradiol and norethisterone acetate. A two-year follow-up study. Hypertantion. 25:1995;848-853
13. Lee K., Greger J.L., Consaul J.R., Graham K.L., Chinn B.L. Nitrate, nitrite balance and de novo synthesis of nitrite in humans consuming cured meats. Am. J. Clin. Nutr. 44:1986;188-194
14. Cicinelli E., Ignarro L.J., Matteo M.G., Galantino P., Schonauer L.M., Falco N. Effects of estrogen replacement therapy on plasma levels of nitric oxide in postmenopausal women. Am. J. Obstet. Gynecol. 180:1999;334-339
15. Cicinelli E., Ignarro L.J., Schönauer L.M., Matteo M.G., Galantino P., Balzano G. Effects of short -term transdermal eastradiol administration on plasma levels of nitric oxide in postmenopausal women. Fertil. Steril. 69:1998;58-61
16. Cicinelli E., Ignarro L.J., Lograno M., Matteo G., Falco N., Schonauer L.M. Acute effects of transdermal estradiol administration on plasma levels of nitric oxide in postmenopausal women. Fertil. Steril. 67:1997;63-66
17. Cicinelli E., Ignaro L.J., Galantino P., Pinto V., Barba B., Schonauer S. Effects of tibolone on plasma levels of nitric oxide in postmenopausal women. Fertil. Steril. 78:2002;464-468
18. Ylikorkala O., Cacciatore B., Paakkari I., Tikkanen M.J., Viinikka L., Toivonen J. The long-term effects of oral and transdermal postmenopausal hormone replacement therapy on nitric oxide, endothelin-1, prostacyclin, and thromboxane. Fertil. Steril. 69:1998;883-888
19. Cagnacci A., Tarquini R., Perfetto F., Arangino S., Zanni A.L., Facchinetti F. Endothelin-1 and nitric oxide levels are related cardiovascular risk factors but are not modified by estradiol replacement in healthy postmenopausal women. A crossectional and randomised cross-over study. Maturitas. 44(2):2003;117-124
20. Imthurn B., Roselli M., Jaeger A.W., Keller P.J., Dubey R.K. Differential effects of hormone-replacement therapy on endogenous nitric oxide levels in postmenopausal women substituted with 17β-estradiol valerate and cyproterone acetate or medroxyprogesterone acetate. J. Clin. Endocrinol. Metab. 82:1997;388-394
21. Castelo-Branco C., casals E., Figueras F., Sanjuan A., Vicente J.J., Balasch J., et al. Two-year prospective and comparative study on the effects of tibolone on lipid pattern, behavior of apolipoproteins AI and B. Menopause. 6:1999;92-97
22. Zandberg P., Peters J.L.M., Demacker P.N., de Reeder F.G., Smit M.J., Meuleman D.G. Comparison of the antiatherosclerotic effect of tibolone with that of estradiol and ethinyl estradiol estradiol in cholesterol-fed, overectomised rabbits. Menopause. 8:2001;96-105
23. Haenggi W., Bersinger N.A., Mueller M.D., Birkhaeuser M.H. decrease of serum endothelin levels with postmenopausal hormone replacement therapy or tibolone. Gynecol. Endocrinol. 13:1999;202-205
24. Hishikawa K., Nakaki T., Marumo T., Suzuki H., Kato R., Saruta T. Up -regulation of nitric oxide synthase by estradiol in human aortic endothelial cells. FEBS Lett. 360:1995;291-293
25. Van-Buren G.A., Yang D.S., Clark K.E. Estrogen-induced uterine vasodilation is antogonised by L-nitroarginine methyl ester, an inhibitor of nitric oxide synthesis. Am. J. Obstet. Gynecol. 167:1992;828-833
26. Scrabin P.Y., Oger E., Plu-Bureau G. Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk. Lancet. 362(9391):2003;1242-1247
27. Beral V. Million Women Study Collaborators. Brest cancer and hormone-replacement therapy in the Million Women Study. Lancet. 362(9382):2003;419-427